Showing 5631-5640 of 19383 results for "".
Building Bridges: A Team-Based Approach to Psoriatic Arthritis Care
https://reachmd.com/programs/beyond-skin-deep/building-bridges-a-team-based-approach-to-psoriatic-arthritis-care/10153/Interacting with multidisciplinary teams is at the core of any strategic PsA care plan. Integrate these tips with your network of physicians.The STELLAR Trial: Key Data on Sotatercept for PAH
https://reachmd.com/programs/acc-action-center/the-stellar-trial-key-data-on-sotatercept-for-pah/15145/Learn more about the STELLAR trial, and find out how it might impact care for patients with PAH.Digital Danger: Understanding AI Psychosis in Schizophrenia
https://reachmd.com/programs/frontlines-schizophrenia/ai-psychosis-in-schizophrenia/49153/As AI technology becomes more advanced and human-like, clinicians are beginning to see a new phenomenon: AI-induced psychosis. In this timely discussion, Dr. Ragy Girgis joins Dr. Alexandria May to explain how large language models can unintentionally reinforce delusions in individuals with schizophConnective Tissue Disorders Update 2025: Dr. Vleugels
https://reachmd.com/programs/practical-dermatology/connective-tissue-disorders-update-2025-dr-vleugels/32673/Ruth Ann Vleugels, MD, PhD, recaps her presentation, "Connective Tissue Disorders Update 2025" at Maui Derm 2025. Dr. Vleugels discussed a new therapeutic for systemic lupus, a new FDA-approved option for dermatomyositis, JAK inhibitors, and more.Updated Criteria for Recognizing Life-Threatening Sepsis and Septic Shock
https://reachmd.com/programs/the-jama-report/updated-criteria-recognizing-life-threatening-sepsis-and-septic-shock/7963/[Read the Article] Sepsis is a clinical syndrome of physiologic, pathologic, and biochemical abnormalities caused by serious infection. Sepsis is a major public health concern. Besides being a leading cause of mortality worldwide, sepsis accounted for more than $20 billion of U.S. hospital costs inDetecting Thyroid Cancer Using Ultrasound Elastography
https://reachmd.com/programs/advances-in-medical-imaging/detecting-thyroid-cancer-using-ultrasound-elastography/3480/Dr. Theodore Dubinksy reviews the conventional use of ultrasound imaging to detect and diagnose thyroid nodules, including fine needle biopsies. He then explains how ultrasound elastography, a newly developed technique, to analyze the stiffness of non-palpable nodules by measuring the amount of distSuprachoroidal Steroids in Patients With a History of Glaucoma and Ocular Hypertension
https://reachmd.com/clinical-practice/ophthalmology/suprachoroidal-steroids-in-patients-with-a-history-of-glaucoma-and-ocular-hypertension/54287/Using steroids in patients with a history of glaucoma, ocular hypertension, or steroid response requires careful monitoring and risk assessment. Could a suprachoroidal route of administration mitigate risk? Maria Berrocal, MD, invites Danny Mammo, MD, to share details from a study he and his colleagSkin Disease and Cardiovascular Risk: Uncovering a Critical Clinical Connection
https://reachmd.com/programs/frontlines-psoriasis/skin-disease-and-cardiovascular-risk-uncovering-a-critical-clinical-connection/32434/Inflammatory skin diseases like psoriasis don’t just affect the skin—they can often reflect broader cardiovascular risks. Given the overlap between dermatology and cardiology, knowing how to spot warning signs early and what steps to take during routine visits is key to comprehensive care. Joining DManaging Dermatitis During Pregnancy: Underlying Mechanisms and Best Practices
https://reachmd.com/programs/dermconsult/managing-dermatitis-during-pregnancy-underlying-mechanisms-and-best-practices/29443/Explore the most common pregnancy dermatoses and learn how immune shifts during pregnancy can contribute to dermatitis.Safety Monitoring of Disease-Modifying Therapies in Multiple Sclerosis
https://reachmd.com/diseases-diagnoses/ms-immune-disorders/safety-monitoring-of-disease-modifying-therapies-in-multiple-sclerosis/31262/Aisha Elfasi, MD, Clinical and Research Fellow, Department of Neurology, Johns Hopkins University, provides an overview of the currently available disease-modifying therapies for multiple sclerosis, highlighting important safety considerations and routine monitoring requirements.